BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
13 results:

  • 1. Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (Nrf2).
    Wang X; Yang J; Li D; Teng L; Chen Y; Meng J; Yang C; Yin Z; Li C
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23689. PubMed ID: 38613465
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sunitinib with photoirradiation-mediated reactive oxygen species generation induces apoptosis of renal cell carcinoma cells.
    Yamamoto S; Nakayama T; Seki H; Kawada C; Fukuhara H; Karashima T; Ogura SI; Inoue K
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102427. PubMed ID: 34216806
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma.
    Wu P; Xiang T; Wang J; Lv R; Wu G
    FEBS Open Bio; 2020 Dec; 10(12):2588-2604. PubMed ID: 33015999
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
    Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
    Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway.
    Nakayama T; Kobayashi T; Shimpei O; Fukuhara H; Namikawa T; Inoue K; Hanazaki K; Takahashi K; Nakajima M; Tanaka T; Ogura SI
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():10-17. PubMed ID: 31404677
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.
    Wallace EM; Rizzi JP; Han G; Wehn PM; Cao Z; Du X; Cheng T; Czerwinski RM; Dixon DD; Goggin BS; Grina JA; Halfmann MM; Maddie MA; Olive SR; Schlachter ST; Tan H; Wang B; Wang K; Xie S; Xu R; Yang H; Josey JA
    Cancer Res; 2016 Sep; 76(18):5491-500. PubMed ID: 27635045
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
    Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
    Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways.
    Selvarajah J; Nathawat K; Moumen A; Ashcroft M; Carroll VA
    Cell Death Dis; 2013 Oct; 4(10):e865. PubMed ID: 24136229
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition.
    Papadimitriou E; Vasilaki E; Vorvis C; Iliopoulos D; Moustakas A; Kardassis D; Stournaras C
    Oncogene; 2012 Jun; 31(23):2862-75. PubMed ID: 21986943
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunochemotherapy-associated protein patterns in tumour tissue and serum of patients with metastatic renal cell carcinoma.
    Walter M; Heinze C; Steiner T; Pilchowski R; von Eggeling F; Wunderlich H; Junker K
    Arch Physiol Biochem; 2010; 116(4-5):197-207. PubMed ID: 20836751
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
    Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
    Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nadroparine activated fibrinolysis and improvement of glomerular filtration rate in patients with FIGO IIB-IIIB cervical cancer treated with radiochemotherapy.
    Derlatka P; Bidzinski M; Stachurska E; Benke M
    Gynecol Oncol; 2007 Jan; 104(1):24-31. PubMed ID: 16959304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.